Biology and applications of mesenchymal stem cells

Science Progress

Volumn 93, Issue 2, 2010, Pages 113-127

  Chagastelles, Pedro Cesar ^b   Nardi, Nance Beyer ^c   Camassola, Melissa ^a  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adult stem cells; Applications; Biology; Cell therapy; Mesenchymal stem cells

Indexed keywords

EID: 77954081777     PISSN: 00368504     EISSN: None     Source Type: Journal    
DOI: 10.3184/003685010X12708175591515     Document Type: Article

References (50)

1. Morrison, S. J. and Spradling, A. C. (2008) Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell, 132, 598-611.
2. da Silva Meirelles, L., Chagastelles, P. C. and Nardi, N. B. (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci., 119, 2204-2213.
3. Huang, A. H., Snyder, B. R., Cheng, P. H. and Chan, A. W. (2008) Putative dental pulp-derived stemystromal cells promote proliferation and differentiation of endogenous neural cells in the hippocampus of mice. Stem Cells, 26, 2654-2663.
4. Mitchell, J. B., McIntosh, K., Zvonic, S., Garrett, S., Floyd, Z. E., Kloster, A., Halvorsen, Y. D., Storms, R. W., Goh, B., Kilroy, G., Wu, X. and Gimble, J. M. (2006) Immunophenotype of human adipose- derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells, 24, 376-385.
5. Huang, X., Cho, S. and Spangrude, G. J. (2007) Hematopoietic stem cells: generation and self-renewal. Cell Death Differ., 14, 1851-1859.
6. Gaudio, E., Carpino, G., Cardinale, V., Franchitto, A., Onori, P. and Alvaro, D. (2009) New insights into liver stem cells. Dig. Liver Dis., 41, 455-462.
7. Suzuki, A., Nakauchi, H. and Taniguchi, H. (2004) Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes, 53, 2143-2152.
8. Barker, N., van de Wetering, M. and Clevers, H. (2008) The intestinal stem cell. Genes Dev., 22, 1856-1864.
9. Fuchs, E. and Horsley, V. (2008) More than one way to skin. Genes Dev., 22, 976-985.
10. Hopkins, C., Li, J., Rae, F. and Little, M. H. (2009) Stem cell options for kidney disease. J. Pathol., 217, 265-281.
11. Kajstura, J., Urbanek, K., Rota, M., Bearzi, C., Hosoda, T., Bolli, R., Anversa, P. and Leri, A. (2008) Cardiac stem cells and myocardial disease. J. Mol. Cell. Cardiol., 45, 505-513.
12. Zammit, P. S. (2008) All muscle satellite cells are equal, but are some more equal than others? J. Cell Sci., 121, 2975-2982.
13. Ahmed, S. (2009) The Culture of Neural Stem Cells. J. Cell. Biochem., 106, 1-6.
14. Nardi, N. B. and Alfonso, Z. Z. (1999) The hematopoietic stroma. Braz. J. Med. Biol. Res., 32, 601-609.
15. da Silva Meirelles, L. and Nardi, N. B. (2003) Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br. J. Haematol., 123, 702-711.
16. Friedenstein, A. J., Chailakhjan, R. K. and Lalykina, K. S. (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet., 3, 393-403.
17. da Silva Meirelles, L., Caplan, A. I. and Nardi, N. B. (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells, 26, 2287-2299.
18. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S. and Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
19. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D. J. and Horwitz, E. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315-317.
20. Horwitz, E., Le Blanc, M. K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Deans, R. J., Krause, D. S. and Keating, A. (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy, 7, 393-395.
21. Haniffa, M. A., Collin, M. P., Buckley, C. D. and Dazzi, F. (2009) Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica, 94, 258-63.
22. da Silva Meirelles, L. and Nardi, N. B. (2009) Methodology, biology and clinical applications of mesenchymal stem cells. Front Biosci., 14, 4281-498.
23. Vrijsen, K., Chamuleau, S., Noort, W., Doevendans, P. and Sluijter, J. (2009) Stem cell therapy for end-stage heart failure: indispensable role for the cell? Curr. Opin. Organ. Transplant., 14, 560-565.
24. Zhou, Q. and Melton, D. A. (2008) Extreme makeover: converting one cell into another. Cell Stem Cell, 3, 382-388.
25. Davani, B., Ikonomou, L., Raaka, B. M., Geras-Raaka, E., Morton, R. A., Marcus-Samuels, B. and Gershengorn, M. C. (2007) Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo. Stem Cells, 25, 3215-3222.
26. Karnieli, O., Izhar-Prato, Y., Bulvik, S. and Efrat, S. (2007) Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells, 25, 2837-2844.
27. Barnabé, G. F., Schwindt, T. T., Calcagnotto, M. E., Motta, F. L., Martinez, G. Jr., de Oliveira, A. C., Keim, L. M., D'Almeida, V., Mendez-Otero, R. and Mello, L. E. (2009) Chemically-induced RAT mesenchymal stem cells adopt molecular properties of neuronal-like cells but do not have basic neuronal functional properties. PLoS ONE, 4, e5222.
28. Nesselmann, C., Ma, N., Bieback, K., Wagner, W., Ho, A., Konttinen, Y. T., Zhang, H., Hinescu, M. E. and Steinhoff, G. (2008) Mesenchymal stem cells and cardiac repair. J. Cell. Mol. Med., 12, 1795-1810.
29. T., Bloch, W. and Schmidt, A. (2008) in vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev., 17, 199-205.
30. Bernardo, M. E., Zaffaroni, N., Novara, F., Cometa, A. M., Avanzini, M. A., Moretta, A., Montagna, D., Maccario, R., Villa, R., Daidone, M. G., Zuffardi, O. and Locatelli, F. (2007) Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res., 67, 9142-9149.
31. Izadpanah, R., Kaushal, D., Kriedt, C., Tsien, F., Patel, B., Dufour, J. and Bunnell, B. A. (2008) Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res., 68, 4229-4238.
32. Aguilar, S., Nye, E., Chan, J., Loebinger, M., Spencer-Dene, B., Fisk, N., Stamp, G., Bonnet, D. and Janes, S. M. (2007) Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells, 25, 1586-1594.
33. Nasef, A., Ashammakhi, N. and Fouillard, L. (2008) Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms. Regen. Med., 3, 531-546.
34. Uccelli, A., Moretta, L. and Pistoia, V. (2008) Mesenchymal stem cells in health and disease. Nat. Rev. Immunol., 8, 726-736.
35. Liotta, F., Angeli, R., Cosmi, L., Fili, L., Manuelli, C., Frosali, F., Mazzingui, B., Maggi, L., Pasini, A., Lisi, V., Santarlasci, V., Consoloni, L., Aangelotti, M. L., Romagnani, P., Parronchi, P., Krampera, M., Maggi, E., Romagnani, S. and Annunziato, F. (2008) Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells, 26, 279-289.
36. Abdi, R., Fiorina, P., Adra, C. N., Atkinson, M. and Sayegh, M. H. (2008) Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes, 57, 1759-1767.
37. Giordano, A., Galderisi, U. and Marino, I. R. (2007) From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J. Cell Physiol., 211, 27-35.
38. Rosenzweig, A. (2006) Cardiac cell therapy-mixed results from mixed cells. N. Engl. J. Med., 355, 1274-1277.
39. Kalil, R. A., Ott, D., Sant'Anna, R., Dias, E., Marques-Pereira, J. P., Delgado-Cañedo, A., Nardi, N. B., Sant'Anna, J. R., Prates, P. R. and Nesralla, I. (2008) Autologous transplantation of bone marrow mononuclear stem cells by minithoracotomy in dilated cardiomyopathy: technique and early results. Sao Paulo Med. J., 126, 75-81.
40. Bernardo, M. E., Locatelli, F. and Fibbe, W. E. (2009) Mesenchymal stromal cells. Ann. N. Y. Acad. Sci., 1176, 101-117.
41. Sudres, M., Norol, F., Trenado, A., Grégoire, S., Charlotte, F., Levacher, B., Lataillade, J. J., Bourin, P., Holy, X., Vernant, J. P., Klatzmann, D. and Cohen J. L. (2006) Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J. Immunol., 176, 7761-7767.
42. Tisato, V., Naresh, K., Girdlestone, J., Navarrete, C. and Dazzi, F. (2007) Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia, 21, 1992-1999.
43. Madec, A. M., Mallone, R., Afonso, G., Abou Mrad, E., Mesnier, A., Eljaafari, A. and Thivolet, C. (2009) Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia, 52, 1391-1399.
44. Djouad, F., Fritz, V., Apparailly, F., Louis-Plence, P., Bony, C., Sany, J., Jorgensen, C. and Noël, D. (2005) Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collageninduced arthritis. Arthritis Rheum., 52, 1595-1603.
45. Gonzalez, M. A., Gonzalez-Rey, E., Rico, L., Buscher, D. and Delgado, M. (2009) Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum., 60, 1006-1019.
46. Jones, B. J. and McTaggarta, S. J. (2008) Immunosuppression by mesenchymal stromal cells: From culture to clinic. Exp. Hematol., 36, 733-741.
47. Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., Andreeff, M. and Lang, F. F. (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res., 65, 3307-3318.
48. Xu, G., Jiang, X. D., Xu, Y., Zhang, J., Huang, F. H., Chen, Z. Z., Zhou, D. X., Shang, J. H., Zou, Y. X., Cai, Y. Q., Kou, S. B., Chen, Y. Z., Xu, R. X. and Zeng, Y. J. (2009) Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats. Cell Biol. Int., 33, 466-474.
49. Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D. and Jorgensen, C. (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 102, 3837-3844.
50. Mishra, P. J., Mishra, P. J., Glod, J. W. and Banerjee, D. (2009) Mesenchymal stem cells: flip side of the coin. Cancer Res., 69, 1255-1258.